What does Gonadorelin do? Benefits and evidence

Gonadorelin copies a brain signal for ovulation and sperm production; fertility studies mainly use frequent pump pulses. Twice-weekly shots alongside testosterone therapy lack comparable fertility evidence. Pituitary tumors, allergy and poorly monitored hormone stimulation are key concerns.

• In studies, timed pulses from a pump helped women whose periods stopped from low brain signals to ovulate. (Studied in a trial)
• In men with diagnosed hormone deficiency, pump treatment can restore sperm production, studies show. (Studied in a trial)
• A pump form (Lutrepulse) was once approved to help women with this hormone deficiency ovulate; it is now discontinued. (Drug label)
• People report adding shots during testosterone therapy to limit testicle shrinkage; fertility benefit is unproven. (Reported by users)

Uses in the sources

• Pituitary LH-response testing is described in authorized UK and French product information. (Clinician-published) (source)
• Pulsatile pumps have been studied for ovulation and sperm production in GnRH deficiency. (Studied in a trial) (source)
• People add intermittent shots to TRT to limit testicular shrinkage; fertility benefit remains unproven. (Reported by users) (source)
• A seven-man Down syndrome pilot explored cognition; this does not establish general nootropic use. (Studied in a trial) (source)